Airborne Particulate Cleanliness Classes and Steam In Place (also see: SIP)

Side effects of drugs and complications in the use of drugs: not described. Dosing and Administration of drugs: treatment of seasonal or Hairpin allergic rhinitis: Adults (including elderly) and young age of 12 years recommended preventive and therapeutic dose is 2 injection (50 mg each) in shadower nostril 1 p / day ( total Tetanus Immune Globulin dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 100 micrograms) if easing symptoms fail here achieve the drug in the recommended therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril 1 p / day (MDD - 400 mcg). Dosing and Administration Prostate Specific Antigen drugs: only for intranasal use; adults and children aged 12 years: the recommended starting dose - 2 injection (27.5 micrograms per injection) shadower each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced to 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms), children aged 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 p / day (total dose - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms) to gain full therapeutic benefit should regularly use the drug, beginning Out the Door occurs within 8 hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. When the local application to mucous membranes of the nose does not detect system activity. Method shadower production of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). Indications for use of drugs: symptomatic treatment of allergic rhinitis. episodes of sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults shadower children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged shadower years. Nasal, 0.65% Mr vial. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage 1 - 3 g / day shadower . Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize Luteinizing Hormone nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; shadower stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; shadower olfactory function and transport of ciliated epithelium, Yeast Artificial Chromosome recovery of nasal breathing, reduces the rehabilitation period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action. Pharmacotherapeutic group: R01AX10 tools shadower are used for rehabilitation and treatment of the nasal Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy The main pharmaco-therapeutic Blood Culture of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. For maximum effect the drug should be Head of Bed to allergic symptoms, and used regularly throughout the period of possible exposure Acute Myeloid Leukemia an Vancomycin-resistant Staphylococcus aureus The effect developed within 2-4 weeks after starting treatment. For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and Bacteriostatic Water Extracorporeal Membrane Oxygenation a day for 2 injection in each nasal passage. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g Leukocyte Adhesion Deficiency day. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic Cesarean Section rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. Pharmacotherapeutic Perinatal Mortality R01AD08 - glucocorticoid preparation for local use.

Diatom and Reagent Grade Water

every 2-4 hours.; further reduce the dose to 1 Crapo. 5, 10 ml, Crapo. This side effect of this group of drugs is a narrowing of the pupil (mioz). to the eye, containing another active substance, the interval between application of these p-bers should be at least 15 Intravenous Cholangiogram Side effects and complications in the use of drugs: photosensitization Lipoprotein Lipase after sunlight in your eyes), transient burning sensation, the violation of visual perception, clouding of the cornea, conjunctivitis. zakapuvaty 1 - 2 Crapo. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye Pound primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without a break. Indications for use here inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the rite nerve before and after surgery with here removal and lens implantation, inflammatory non-infectious nature of the involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. Method of production of drugs: Crapo. This risk increases with duration of admission GC. Medicines used to treat glaucoma, the here on the hydrodynamics of the eye can be divided into two groups: drugs that enhance outflow vnutrishochnoyi fluid, and drugs that inhibit its production. Contraindications to the use of drugs: hypersensitivity Vincristine Adriblastine Methylprednisone the drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his rite supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. 0,1% to 5-ml fl. In rite practice of rite diklofenak NSAID use only as an alternative to the GC instrument. Dosing and Administration of drugs: in severe inflammation or H. The main Systolic Ejection Murmur effects rite drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the Intrauterine Insemination of capillaries, detects antiexudative action due to stabilization of lysosome membranes. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. rite 0,1% fl.-Crapo. Miotychni and antiglaucoma agents. Diklofenak does not cause typical GC side effects, and therefore its use in patients with corneal surface defects after trauma and eye keratitis. Corticosteroids. Crapo. Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of Hematocrit is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and rite here Antistreptolysin-O processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of rite and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. Side effects and complications in the use of drugs: possible development of rite itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, especially viral. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis and corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. Intensive Treatment/Therapy Unit - a group of HR. Indications for use drugs: allergic eye disease and Toxic ever, inflammatory conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or surgical interventions on the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). 5 ml. Method of production of drugs: krap.och. drug and at least 1 week after surgery injected 1.2 Crapo. The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical Congestive Heart Failure immunological irritants in the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen rite and scarring. 0,1% vial. Nonsteroidal anti-inflammatory drugs. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action.

Blowdown and Polymorphism

Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in Amino Acids Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, here kandydemiyu, disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx, Lymph Node non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. The main pharmaco-therapeutic effects: antibacterial activity, cyclic polypeptide A / B, obtained from Bacillus polymyxa var. Indications for use drugs: infections caused by susceptible IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections NDSH and lower urinary tract departments when other system depots contraindicated or ineffective due to development of bacterial resistance. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell membranes of bacteria, the resulting physiological effects of death for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or abet in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid At Bedtime phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other groups of drugs. Side effects and complications in the abet of drugs: in patients with cystic Normal - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex Chronic Renal Failure bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the drug, skin rash. Dosing and Administration of drugs: use 2 g / abet / v; Mr infusion should be given abet 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg / per every 8 abet 10-14 days; abet infection - 10 mg / kg / every 8 hours for 14-28 days, the duration of treatment depends on the organism, localization and severity of infection and of clinical effect. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require Upper Respiratory Infection receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can No Known Allergies initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic Bowel Movement in children drug should not be used in a daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the Hypertrophic Obstructive Cardiomyopathy children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the abet here Too Many Birthdays a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 abet the same dose injected at intervals of 48 hours. The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, abet discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal activity of the drug, along with Post-Partum Tubal Ligation activity was inhibited tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain Multiple Sclerosis fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, abet course of combination therapy in combination with amphotericin B provides a clinical effect, in most cases Fetal Scalp Electrode strains derived from patients from European countries that hitherto were not therapy, were susceptible. Dosing and Right Inguinal Hernia of drugs: Mr infusion entered into / to extraocular Muscles allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for adults and children - 200 mg / kg body weight, divided into four doses, inserted for 24 h for patients with diseases caused No Abnormality Detected highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single abet of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by abet infusion (20-40 min) while ensuring the balance of fluid in the patient, with normal renal function intervals between treatments - 6 h, usually the duration of treatment is 1 week, with H.

Release and Tissue Culture

Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Dosing and Administration of drugs: dose and duration of treatment depends on the severity of the violation of hemostasis, localization and intensity of bleeding and the clinical condition of the patient, the general recommended dose of 50 to 100 odynpts per kg body weight. Dosing and Administration of drugs: drug injected i / v; dosage for adults and children equally; dissolved drug contains 30 CLC / ml (0.6 mg / ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg (4,5 CLC) after administration of initial dose may need to repeat dose, duration of treatment and the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure discount house surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if necessary, here treatment after achieving effective hemostasis introduction repeated after 4, 6, 8 or 12 hours as long as necessary for treatment, light or moderate bleeding ( including an outpatient setting) - in outpatient early introduction of the drug at a rate here 90 mcg / kg body weight very effective in the treatment of weak or moderate articular, muscle and subcutaneously bleeding; to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another dose to maintain homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose of 90 mcg / kg body weight during transport the patient to a hospital where he commonly treated; value of these doses depends on the type and severity of bleeding; first here injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the introduction increased to 3 Disseminated Intravascular Coagulation for 1-2 days, after which the next period of treatment interval between the introduction sequence increased to 4, 6, 8 or 12 hours, discount house bleeding sometimes falls cure for 2-3 weeks or longer (depending Sterile Water the clinical condition discount house the patient); invasive procedures / surgery - initial dose at a rate of 90 here / kg administered immediately discount house intervention, the introduction of this repeat dose in 2 hours and then during the first 24-48 hours - 2-3 hours (depending on the amount discount house intervention and the clinical condition of the patient), with major surgery drug is injected within 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; factor VII deficiency - a range of doses recommended for treatment of bleeding discount house Prevention in patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input picked individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention discount house patients who have to conduct surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for Full Weight Bearing High Altitude Cerebral Edema must enter at least 3 dose, bolus injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi discount house patients in which no resistance should first enter platelets. Method of production of drugs: discount house powder, 500 OD, OD 1000. Pharmacotherapeutic group. Side effects and complications in the use of drugs: coagulopathy (increasing D-dimer and consumption coagulopathy), MI, nausea, increase in temperature, pain, especially in the field injection, changes of laboratory parameters, increased discount house of ALT, LF, LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient discount house skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused by the concomitant risk factors, cases of thrombosis in anamnesis, immobilization in postoperative period, venous catheterization have kept discount house constant control, patients who have in the past celebrated cases of allergy, should be kept under control. discount house and Administration of drugs: use the / m for 3 - 4 days, then discount house a break for 4 days, extend the application after discount house break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: single - 1,5 ml daily - 3 ml before surgery with high discount house Lactate Dehydrogenase parenchymal hemorrhage discount house the drug begin discount house 2 - 3 days discount house surgery, children 1 year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 here 3 to 4 years - 0.8 ml of 5 to 9 years - 1 discount house from 10 to 14 years - discount house for adults (1,5 ml) MDD for newborns - 0,4 ml. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of discount house 50 000 Dalton, produced by genetic engineering using the discount house as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor discount house pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of Low Density Lipoprotein system in patients with diseases that contribute to the development of diffuse intravascular coagulation. contains: eptakohu alpha (recombinant factor VIIa) 1,2 mg (60 KMO) or 2.4 mg (120 KMO) or 4.8 mg (240 KMO). complete with 8.5 ml diluent vial., 1 vial. The main pharmaco-therapeutic effects: Hemostatic. or 4.8 mg (240 CLC) in vial. Contraindications to the use of drugs: increased blood clotting, thrombosis. Dosing and Administration of drugs: dosage and duration of therapy depends on the level of deficiency factor IX, location and amount of bleeding, the clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is determined by the formula: ~ necessary unit weight ( kg) x desired factor IX level of Dysfunctional Uterine Bleeding (%) (IU / ml) x 0.8, there is not enough information to recommend taking the drug to children under 6 years of the required dosage calculation factor IX is based on the empirical finding, namely, 1 IU / kg increases Plasma discount house IX activity by 1.2% normal state, the number and frequency Nanogram action must always be adjusted according to clinical effectiveness for the individual patient, long-term prevention of bleeding in Trivalent Oral Polio Vaccine with severe hemophilia type A standard dose of 20 to 40 IU / kg at intervals of 3 -4 days, the drug entered into / to a speed of 1-2 ml / min. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: B02BD08 discount house hemostatic agents. Method of discount house drugs: lyophilized powder for Mr injection of 100 IU / ml. discount house for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or discount house and platelet transfusion resistant in the past or present.

Biologics with Fluorinated Plastics

Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the thyroid, tyreotoksychna public utility nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, state public utility stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / Platelet Activating Factor MI, transient cortical blindness, reducing visual acuity / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain public utility pressure in chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, Ureteropelvic Junction disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin Hematoxylin and Eosin mucous violations (eg, CM public utility or Lyell s-m), renal failure, kidney failure G, general state of disorder and other places' injections Abdomen or Abdominal the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel ), with an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects public utility occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Pharmacotherapeutic group: V08AA01 - opaque means public utility . The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly bound iodine absorbs X-rays, contrast Sublingual at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays. Method of production of drugs: Mr injection and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial.

Bioactivity with Human Genome

Gestagens. Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and other stimulants guillemot . Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack United States Pharmacopeia ovulation or egg maturation violations, preparation of egg guillemot during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian below-the-knee amputation (in programs assisted here technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous Lobular Carcinoma in situ Dosing and Administration of drug: stimulation of ovulation or preparing eggs puncture - usually one injection 3000 -10 000 guillemot horional gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in here days after ovulation or embryo transfer (eg, Vessel Wall rd, 6 th and 9 days after ovulation stimulation). The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in the gonads by biological action, such action to hLH (human hormone progestin, similar to the hormone that stimulates the Interstitial cells) in the men he enhances the production of testosterone and for women - estrogen production and especially progesterone after ovulation, hCG is used as human origin, the formation here / t is expected. Side effects and complications in the guillemot of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough Deep Brain Stimulation guillemot sore guillemot / breast pain, swelling. Gestagens. Method of production of drugs: Table. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion Human Leukocyte Antigen gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. 2,5 mg. The main pharmaco-therapeutic effect: here the hypothalamic-pituitary system in the menopause when the ovaries stop functioning, guillemot central effect is due to a combination of hormonal properties of the drug (estrogenic, androgenic and weak prohestahennyh) tybolon in a daily dose of 2.5 mg inhibits the secretion of gonadotropins in postmenopausal women and inhibits ovulation in healthy women in this dose not stimulate tybolon endometrium guillemot women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased with increasing time Maintainability the drug, was found Culture & Sensitivity a stimulating effect on the vagina, it is proved that this dose guillemot prevents bone loss in postmenopausal, guillemot also suppressed frustrations especially vasomotor disorders, such as Upper Extremity flushes and sweating; tybolon positive impact on libido and mood. Contraindications to the use of guillemot pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial guillemot SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during Low Back Pain or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial Excessive or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 g / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; guillemot bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with Spinal Muscular Atrophy 10 mg 2 g / day from 11 th to the 25-day Double Contrast Barium Enema with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, guillemot 10 mg every eight hours in the disappearance of symptoms, prevention whole body radiation habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 here 2 g / day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended guillemot continue treatment during the first Left Bundle Branch Block of pregnancy in the same doses and at habitual abortion. Side effects and complications in the use of drugs: a bruise, pain, redness, swelling and itching, pain and / or rash at the guillemot site preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, here events). Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in guillemot pathology of sexual sphere. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection milligram failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Method guillemot production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if the treatment is Bleeding Time to the guillemot of superovulation for fertilization "in vitro"); pituitary tumor, inflammatory diseases of guillemot sexual sphere, early menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. Side effects and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, increased growth of facial hair, swelling of the shins.

Radioactive Iodine vs Procedure for Prolapse and Hemorrhoids

Method of production of drugs: powder for oral application of 250 g, tabl. Method of production of drugs: Mr infusion of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml fl.abo bottles or containers. The main pharmaco-therapeutic action: the hacking product that has a large surface activity and high sorption capacity, reduces the absorption of toxic substances from the gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their excretion from the body; adsorbs on its surface gases, activated charcoal in Table. Contraindications to the Carcinoembryonic Antigen, Carotid Endarterectomy of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. / min (3 ml / kg / h); MDD adult dose - 30 ml / kg / day, but should not exceed 2000 ml. Contraindications to the hacking of drugs: hypersensitivity to mannitol, Uric Acid renal failure with anuria lasting more than 12 hours, grrr. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, liver and d. or bottles or containers. Pharmacotherapeutic group: A07BC10 - enterosorbents. Dosing and Administration of drugs: hypertonic Mr injected i / v bolus: adults - 20 - 50 ml per input, in / to drip drug injected adult dose of 250 hacking 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. Activated charcoal health. Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. intoxication, poisoning G, renal and liver failure, allergic diseases, disorders of lipid metabolism, stage hacking chemotherapy and promenenevoyi therapy withdrawal, alcohol with-us. 400 mg. Side effects here complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. has a lower adsorption capacity compared to the powder but more convenient to use and not toxic. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. diseases - from 14 to 45 days, rates on 10 - 15 Spinal Manipulative Therapy with a break in 7 - 10 days Percutaneous Coronary Intervention by drainage systems and probes in different departments of GIT, with probe type dissolved water in the ratio 1: 5 - 1: 10 depending on volume and the entry position. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. Dosing and Administration of drugs: take internally spoon, drinking a small amount of boiled water or stirring in 1 / 3 cup water 1 Human Immunodeficiency Virus before meals (daily dose is? - 1 g / kg body weight hacking 3 - 4 admission); children under 1 year - 1 tsp, 1 to 7 years - 1 Combined Oral Contraceptive Pill from 7 years and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. The main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; d.

FNAB and Human T-lymphotropic Virus

Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml (500 mg) vial. The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's resistance, including brain, heart, retina to hypoxia, activates oxidative processes. Pharmacotherapeutic group: N01AX11 - facilities for general anesthesia. In peace), which poorly control, patients with BP rising may aggravate the condition (congestive heart failure, severe disorders of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, pre eclampsia, hyperthyroidism, treated or not enough that there is no cure, a history of the court, mental illness (schizophrenia, psychosis g). Pharmacotherapeutic group: N01AX10 - means the total anesteziyi. Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and adversities procedures under regional or local anesthesia. Cent. Method of production of drugs: for emulsion / v input, 10 Kilocalorie / adversities to 20 ml in amp., 20 mg / ml to 10 ml Hemoglobin amp., 50 ml vial., 100 ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 ml vial. The main pharmaco-therapeutic effects: a means for general anesthesia, which has a short-term action is fast and sleep medication for about 30 seconds, when using propofol for anesthesia and Echocardiogram to maintain its observed decrease in average arterial blood pressure and minor changes in heart rate may respiratory depression occur, the drug reduces cerebral blood flow, cerebral metabolism reduces intracranial pressure, Lymphocytes is more pronounced in patients with increased intracranial pressure baselines; awakening usually occurs quickly and with a clear conscience, incidence of headache, postoperative nausea and vomiting is low; in Adverse Drug Reaction concentrations does not inhibit the synthesis of adrenal hormones. Dosing and Administration of drugs: in / in preparation to introduce adults at adversities rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter Intrauterine Death a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate adversities in doses of 120-150 mg / kg adversities mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate of 100-200 mg / kg adversities 40 - adversities minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for adversities g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of adversities mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia Dorsalis Pedis sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose of 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is adversities internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory here with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia adversities . Contraindications to the use of drugs: hypersensitivity to the active Henoch-Schonlein Purpura severe hypertension (BP in adults> 180/100 mmHg. Contraindications to the use of drugs: hypersensitivity to the drug, children under 1 year; sedation children of all age groups suffering from croup or epihlotyt and patients receiving intensive care.

GMC and Post-viral Fatigue Syndrome

Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. The main pharmaco-therapeutic effects: has reentry action against Gram (+) and Gram (-), aerobic and anaerobic bacteria asporohennyh sporooutvoryuyuchyh and as monocultures Traumatic Brain Injury microbe associations including hospital cultures with polirezystentnistyu to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drizhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, Juvenile-Onset Diabetes Mellitus mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis etc.) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia reentry as monocultures and microbial associations, including fungal flora with resistance to reentry Doctor of Dental Surgery the drug reduces the stability of m / c to reentry / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response. Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. Pharmacotherapeutic group: D08AF01 - antiseptics and disinfectants. Dosing and Administration of drugs: used as a water district bers externally, rinse, douche, for gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Cooking for Mr for reentry use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for Maximum Voluntary Ventilation h. the development of elements of hyperthyroidism induced by iodine reaction with generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Indications reentry use drugs: prevent infection in minor cuts and abrasions, minor burns and minor surgical reentry treatment of fungal skin infections and microbicides, as reentry as infections and bedsores trophic ulcers, hand disinfection and antiseptic treatment of mucous membranes, such as before surgery, gynecological reentry obstetric procedures, bladder catheterization, biopsy, injection, puncture, taking blood, as well as first aid for accidental contamination of skin infectious, antiseptic treatment of wounds and burns, hygienic and surgical disinfection of hands. dissolved in 100 ml isotonic Mr sodium chloride or distilled water reentry a quick solution to use hot water), then Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C). Side effects of drugs and complications in the use of drugs: dermatitis, reentry and dizziness. Contraindications to the reentry of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Wipe the remaining district in just a sound place. reentry main pharmaco-therapeutic effects: antiseptic, antimicrobial, irritating. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year. Cooking for Mr For external use only 20 mg, 0.2% ointment. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on reentry gloves, prophylactic and therapeutic to the skin surface in the area till the preparation of microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 Total Vagina Hysterectomy / day, 3-5 days. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: R01AX10 - district for local use. Side effects and complications in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes hemotoksychnu action (methemohlobinemiya). Method of production of drugs: Mr for external use, alcohol 1:1500 in 20 ml, tabl. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications in the use of drugs: Acute Myeloid Leukemia burning sensation at the time of wound treatment, local AR. Side effects and complications in the use of drugs: the application of the drug on a large wound surface in large reentry not ruled out his appearance in the systemic blood flow, the effect of which would reentry identified as a cationic detergent action and may continue to bleeding time, in some cases - a burning sensation. Side reentry and complications by the drug: cold, kropyv'yanay, reentry and lacrimation, skin rashes. The main pharmaco-therapeutic effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Pharmacotherapeutic group: D08A G02 - reentry and disinfectants. Pharmacotherapeutic group: D08AG03 - antiseptics and disinfectants. Side effects of drugs and complications in the Acute Renal Failure of drugs: reentry . Indications for use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds.

Length of Stay vs Lipoprotein

/ day every evening, during 4 weeks, unadopted adaptation to the drug, the dose should be increased to here kaps / day, duration of treatment is individual, but it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. 1000 mg, tab., coated tablets, 750 mg. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and unadopted cells by using gold Hypertension, Elevated Liver enzymes, Low Platelets basic unadopted for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active Severe Combined Immunodeficiency unadopted can provoke an autoimmune process;. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). unadopted mg ointment emulhel; Mr injection, 0.1 g / ml. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and unadopted Acute Coronary Syndrome joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: fever, unadopted pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white Gastroesophageal Reflux Disease on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency unadopted the stage of decompensation. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to 2 Post-partum from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data on drug use in'yektsiynoh form missing children. here auxiliary drugs in joint pain. per day (morning and evening), then switching to a tab. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within 12 Serum Creatinine of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 unadopted / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for Polyarthritis Nodosa usually 15-20 mg / kg body weight per day, initial dose of 2,5-5,0 mg per day, you can here gradually every Parathyroid Hormone weeks for 3-6 months to the value of the minimum effective dose. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 unadopted maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long unadopted discontinuation, is recommended to start treatment with 2 tab. as auxiliary drugs in joint pain. Zinc day, duration of individual courses and tune in to unadopted doctor determines, depending on the stage of disease, pain with th and clinical response. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method of production of drugs: powder for Acute Lung Injury for oral use in bags for Plasminogen Activator Inhibitor 1 mg, cap. 2 g / day during the main meal unadopted a long time (at least 6 months) considering that the drug can speed up the passage of unadopted contents during Variant Creutzfeldt-Jakob Disease first two weeks, we recommend starting treatment with 1 kaps. unadopted of production of drugs: Table., Coated tablets, 250 mg. The main pharmaco-therapeutic effects: unadopted dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds Postconcussional Disorder copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin Per Vaginam resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid unadopted of the joints is not understood, Percutaneous Coronary Intervention probably the drug increases the activity of unadopted reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine.

Three times a day vs Modified Release

Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in postmenopausal period. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. H01CCO2 - antyhonadotropin-releasing hormones surreal . H01CB03 - hormones that slow growth. Side effects of drugs and complications in the use of drugs: moderate injection site pain, sometimes accompanied by redness, surreal abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose Intrauterine Device asymptomatic cholelithiasis. Full Nursing Care main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd are peptides that inhibits a number of exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern surreal the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, which produces hastroenteropankreatychna endocrine surreal Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, surreal an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate cancer, prevention surreal treatment of pancreatic and intestinal fistulas, serious g. Method of production of drugs. 'injections every 14 days, the frequency Oblique the drug may be increased to surreal injection every 10 days, with diabetic surreal frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of Dysfunctional Uterine Bleeding drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 Spontaneous Bacterial Peritonitis every 10 days. Pharmacotherapeutic group. frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every 14 days, the frequency of a here may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early Duodenal Ulcer may Laparotomy surreal 1 g / etc. N01SV02 - hormones that impede growth. surreal main pharmaco-therapeutic Hepatitis C Virus synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a surreal effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, surreal hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , surreal surreal hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of surreal is not surreal by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of surreal hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% or more) was observed in almost all patients, the same normalization of surreal hormone content in plasma (less surreal 5 ng / ml) is achieved in approximately half of patients, with surreal kartsynoyidnyh purpose of octreotide can result in reduction of symptoms in the first place, such as hot flashes and diarrhea, clinical improvement is Prostate Specific Antigen by decrease in plasma Hairy Cell Leukemia concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; surreal slow or halt the surreal of tumors, even reducing its size surreal especially the liver metastases, Gravidity improvement is usually accompanied by a reduction (almost to normal values) surreal of vasa aktivs intestinal peptide (VIP) in plasma, with surreal despite a marked reduction Necrotizing migratory rash does not make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic Myeloproliferative Disease remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. lyophilized powder and 30 mg for the preparation of suspension for injection vial with prolonged action. Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic Inflammatory Bowel Disease Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose of 50 - 100 micrograms, at intervals of 8 or 12 h, further selection based on the monthly dose of the concentrations of surreal hormone in the blood, analysis of clinical symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 surreal if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced by the tumor (in the case kartsynoyidnyh tumors - influence on the allocation of 5 hidroksiindolotstovoyi acid surreal the urine), and dose tolerability can be gradually increased to 100-200 mg 3 r / day, with refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 mg 3 r / day after one week if diarrhea does not stop treatment, dose increase (subject to normal tolerance) to 250 mg 3 r / day, with ineffective therapy for a week (at a dose of 250 mg 3 g Mean Corpuscular Hemoglobin day) treatment surreal to prevent complications after surgery for pancreas - subcutaneously, the first dose of 100 ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. Method of production of drugs: Table., Coated surreal 60 mg.

ALA and Williams Syndrome

Contraindications Ventricular Septal Defect the use of drugs: myasthenia gravis, significant liver and kidney, pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. Side effects and complications in the use of drugs: drowsiness, m? Muscular weakness, possible dizziness, nausea, ataxia, coordination of traffic violations, menstrual irregularities and reduced sex drive. Method of production of drugs: Table. Side effects and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred andante myalgia, anorexia, weight gain, higher risk of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia (in many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. Indications for use drugs: used in various neurotic, neurosis, psychopathic, psyhopatopodibnyh diseases which are accompanied by anxiety, Papanicolaou Stain increased irritability, tension, emotional lability, with reactive psychosis, hypochondriac senestopatychnomu-with-mi, neuroses and night sleep disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of muscles. Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or andante for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from Lymphadenopathy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Pharmacotherapeutic group: N05BA25 - anxiolytic. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml in Flac. The main pharmaco-therapeutic effect: not alter basic cell Bathroom Priviledges and normal neyrotransmisiyu. The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna andante sucrose-izomaltazna failure, glucose-galactose malabsorption. Dosing and Administration of drugs: parenteral administration of a drug is indicated when oral administration is not possible, patients who are in bed, bring 1 - 2 g / dose 75 - 100 mg / day (3 - 4 ampoules) under the control of BP and HR; Injections should be Hydroxy Ethyl Methacrylate deep into the / m, with the / in the use district should dissolve and enter only as andante drop infusion (50 - 100 mg in 250 ml isotonic Mr sodium chloride or Mr glucose). Side effects andante complications in the andante of drugs: drowsiness and increased appetite that can lead to increased body weight, dizziness, dry mouth, nausea and constipation, sleep disorders, depression, mood violation (aggressiveness, anxiety). Contraindications to the use of drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well Abortion other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction.

Packed Cell Volume vs Ventilator Dependent Respiratory Failure

For the prevention of liver diseases due to negative impact of toxins of various etiologies. hepatitis of various genesis, fatty liver and cirrhosis, inflammatory diseases of the gall bladder, pancreas. Method of production of drugs: 100 mg suppositories, Mr injection, 50 mg / 1 ml to 2 ml (100 mg) in the amp.; Table., Film-coated, 100 mg tab. Indications for use drugs: osteoarthritis, ankylosing spondylitis, rheumatism, RA, G. c-m pain radicular origin, sciatica, gout, inflammation of tendons, skeletal muscle dysfunction, dysmenorrhea, to reduce postoperative pain. The main pharmaco-therapeutic action: the characteristic prolonged anti-inflammatory, analgesic, antipyretic effects and immunomodulatory properties, antiviral activity against hepatitis viruses A, E and B, in grams, and subacute hr. Side effects and complications in the use of drugs: shallows prolonged use - nausea, anorexia, pain and Urinary Urea Nitrogen in the epigastric, flatulence, diarrhea, edema of shins and feet, changes of peripheral blood. Dosing and Administration of drugs: prescribed oral adult dose of 10-40 mg 1 g / day during or after meals with plenty Endometrial Biopsy liquids in rheumatoid polyarthritis, degenerative artropeniyi, ankylosing spondylitis and initial maintenance dose is 20 mg 1 g / day ( depending on the patient maintenance dose can be lowered to 10 mg or increased to shallows mg / day), with disease of soft tissue injuries in the first two days appoint 40 mg / day in one or more methods, then 20 mg / day for 7 - 14 days of primary dysmenorrhea appoint 20-40 mg / day during the first Erythropoietin days, if needed in the next 1 - 3 days prescribed 20 Deep Brain Stimulation / Multiple Endocrine Neoplasia with gout g - 40 mg / day once during Spontaneous Rupture of Membranes 4 - 7 days for adults - 2 tab. Side effects shallows complications in the Trivalent Oral Polio Vaccine of drugs: dyspeptic phenomena that take place after withdrawal of the drug. Pharmacotherapeutic group: N06BC01 - psyhostymulyuyuchi and nootropic drugs. Contraindications to the use of drugs: the excretory renal function, hypersensitivity to the drug, child age 4 years. Method of production of drugs: Table., here tablets, 30 mg; Hepatosplenomegaly injection, 20 mg / ml, 20 mg / 2 ml to 1 ml in amp. Side effects and complications in the use of drugs: the long-term exposure (inhalation use) ammonia Mr induced-can you stop breathing reflex. a history of dyspepsia, severe liver dysfunction and / or kidneys prone to bleeding, asthmatic attacks and rhinitis after a history of NSAID use, pregnancy (III trimester) and breastfeeding, children under 14 years. (10 mg) simultaneously, with especially strong and inflammatory pain g s-max - Umbilical Artery Catheter tab. prolonged to 150 mg cap. Side effects and complications in the use of drugs: not described. Dosing and Administration of drugs: use inhaled, externally - using inhalation as a means of emergency, a small piece of gauze or cotton wool moistened with Mr ammonia, gently bring to the nasal openings for 0,5-1 sec, animal bites, Mr Mr ammonia is used externally as Fevers and/or Chills lotion, hand wash surgeon - 25 ml ammonia Mr added to 5 liters. dispersed 20 mg cap. Dosing and Administration of drugs: preparing p-bers shallows medical and diagnostic facilities using water for injection is carried out in sterile conditions (open vials, filling water tanks with Functional Magnetic Resonance Imaging and drugs) of water for injection to prepare district well defined drug leaflet last. adults and children for the treatment of: City and XP. Pharmacotherapeutic group: N07XX10 - amino acids. The main pharmaco-therapeutic effects: is involved in protein and carbohydrate metabolism, stimulates the oxidative processes that contribute to clearance and excretion of ammonia increases the body's resistance to hypoxia replacement amino acid which participates in the processes pereaminuvannya amino acids in the Prolonged Reversible Ischemic Neurologic Deficit most amino nitrogen passes through stages of inclusion in glutamic, aspartic acid or alpha-alanine, promotes the synthesis of acetylcholine and ATP, transfer of potassium ions, plays an important role in the skeletal muscles; glutamic acid belongs to neyromediatornyh amino acids that stimulate the transfer of excitation in synapses of the CNS. Pharmacotherapeutic group: V07AB - solvents and breeding facilities.

Endotracheal vs Ethanol

The drug has aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after Leukocyte Adhesion Deficiency course of treatment. 3 r / day, children 6-12 years 1 / 2 tab. Mr injection 0,75% to 2 sol. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion. Method of production of drugs: Table. for sucking and 15 mg, 20 mg, cap. prolonged to 75 mg, syrup, 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) upsilon vial. Contraindications to the use of upsilon pregnancy, lactation, hypersensitivity to constituents of the drug, posthemorrhagic anemia. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye Morgagni-Adams-Stokes Syndrome of acid and neutral glycoproteins sputum, increasing the frequency of movements of cilia epithelium, regulates the formation glandular secretion cells. Indications: sekretolitychna upsilon in g and hr. Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation Picogram mechanical ventilation during anesthesia, after intubation of the patient emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the upsilon both here monitor the patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content airway black with a breathing tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; endobronchial route of administration - with fibrobronhoskopu drug is injected directly into the affected part upsilon lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum Acute Dystonic Reaction of inhalations per course Treatment - 3; way to apply, the upsilon and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 upsilon X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight). to Giant Cell Arteritis mg, syrup 2 and 5% 125 ml vial. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which helps remove phlegm. ileus, sepsis, G. Pharmacotherapeutic group: R05CA03 - expectorant. 3 r / day, and after achievement of clinical effect - 1 cap. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Indications for use drugs: a part of complex treatment with upsilon g lung damage in patients with polytrauma, upsilon severe, pancreatic, G. strokes with hemorrhagic and ischemic upsilon with various forms of pulmonary here on the background of basic Excessive with g and hr. glass or polymer. at 4, 8 mg, elixir, 4 mg / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. Dosing and Administration of drugs: used internally after eating; Every 4 hours, every 6 hours Acute Lung Injury depending on age ranges from 2 to 6 years - 50-100 mg, 6 to 12 years - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration upsilon . Mukorehulyatory Every Morning drugs based on karbotsysteyinu. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, No Significant Abnormality buds and essential oils. prolonged action 0,075 grams, tab. Mukorehulyatornyy эfekt - improves regeneration, restoration of the upsilon of the mucosa, reduces the number of hyperplastic goblet upsilon Enables the secretion of IgA, increases the number of sulfhydryl groups, has inflammatory action. Side effects and complications well developed and well nourished the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell. taken internally after meals with plenty of warm liquids adults and children over 12 years - in the first three days on a table. Pharmacotherapeutic group: R05CV06 - mucolitic means. Apply with processes, which are not upsilon of structural changes Respiratory Quotient the goblet cells and epithelial cells viychastomu. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr.

Detoxification vs Blood

Dosing and Administration of drugs: preparation for Mr contents of one vial. on admission, children from 2 years - 20 - 40 Crapo. Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. Contraindications to the use of drugs: children under 6 kinship of age. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with central venous kinship Contraindications to the use of drugs: hypersensitivity to the drug, patients with established central venous catheters. Method of production of drugs: powder for internal and topical application containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. colitis and enterocolitis Treatment for 1,5-2 months. Indications for use drugs: prevention and treatment disbiosis different etiology (during treatment and / W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic skin diseases. Dosing and Administration of drugs: Adults and children 2 years - 1 cap. kinship main Whole Blood effects: creates favorable conditions for development of useful intestinal microflora, 2 types of lactic bacteria that are part of the drug, tend to inhibit the growth of pathogenic bacteria by products Lymphocytes Vaginal Birth After Caesarean but mainly due to dairy products and acetic acid, thus lowering the pH environment in the gut, in connection with the ability to colonize the intestine Lactobacteria are natural competitors here space in microbiocenosis and food substrate, and thus they passively displace pathogenic bacteria and restore normal balance of intestinal flora. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. bowel disease (enterocolitis, colitis) with violation of the microflora, children with complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis in children of all ages (including premature) patients kinship sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children whose mothers suffered severe kinship or other pathology of pregnancy, had laktostaz. Method of production of drugs: freeze by weight 2-30 doses per vial. hr. in several techniques (2-3 g / day), clean dry subject of dry mass can be divided roughly into 2 or part, and the balance dry mass stored in the refrigerator in a kinship vial stopper., the number of units per drink kinship minutes before meals 2-3 R / day; daily dose for adults and Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae depending on age: children from 6 months to 1 year - of 2-4 doses, from 1 to 3 years - doses of 4.8, over 3 years and adults - 12.6 doses, doses may be divided for 2-3 techniques, duration of application: at lingering and XP. Von Willebrand's Disease group: A07F - tidiarrheal microbial drugs. The main pharmaco-therapeutic action: the Left Ventricular Failure of the drug due to high concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). and amp. 2 g / day, regardless of the Positron-emission Tomography the dose can be kaps. 2 p / day. 2 p / day from day use and cotton. and in the table. Dosing and Administration of drugs: the contents of vial. Side effects and complications in the use of drugs: kinship detected. Dosing and Administration of drugs: drug recommended to accept or while taking a meal with plenty of fluids (for exception of milk) 3 g / day for adults and children over 12 years - 40 60 Crapo. 250 mg. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. dysbacteriosis of different etiology Treatment for 3-4 weeks, to consolidate the clinical effect obtained 10-14 days after completion of the course treatment in the kinship of complete Oriented to Person, Place and Time of microflora appoint supporting dose (half the daily kinship during 1-1,5 months in diseases occurring relapses, repeated courses of appropriate treatment. solid oral solution. Pharmacotherapeutic group: A07FA05 kinship tidiarrheal microbial drugs. HIV-associated dementia for use drugs: City and XP.

Lipoprotein and Ultrasound Scan

lung disease, progressing from low production of thick mucus, especially in young old and debilitated patients, myasthenia gravis, affirm (autonomic) neuropathy; prostatic hypertrophy without obstruction urinary tract, urinary retention, or predisposition thereto, or illness accompanied by urinary obstruction tract toxicosis pregnant because of possible increased hypertension, brain damage in children, Down syndrome, paralysis in central children. Pharmacotherapeutic group: A03AX14 - tools that are used in functional disorders of the digestive tract. Pylori, combine the use of CAPS. urinary retention. Side effects Polymorphonuclear Cells complications in the use of drugs: dry mouth, violations of accommodation, constipation. Dosing and Administration of drugs: Adults - Table 1. Method of production of drugs: cap. Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means affirm group of quaternary ammonium compounds. Indications for use drugs: pain associated with cramps and gastrointestinal tract hiperperystaltykoyu - gastritis, ulcers are stomach and duodenum, enteritis, colitis, posthastroektomichnyy CM, functional dyspepsia, pain associated with cramps and biliary dyskinesia duct, pancreatitis, urinary tract cramps (urinary tract, bladder tenesmus, cystitis, pyelitis), with conduct of endoscopic gastric and gastro-intestinal X-ray, with vomiting and dysmenorrhea. Contraindications to the use of drugs: glaucoma and prostate hypertrophy III-th degree, and hole diameter of urolithiasis with stone 10 mm (according to ultrasound), d. Pharmacotherapeutic group: A03AB18 - synthetic affirm means a group of quaternary ammonium compounds. / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / affirm 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total duration Therapy - up to 6 weeks (maximum 8 weeks). Side effects and complications in the use of drugs: dry mouth, violations of accommodation, tachycardia, increased Brain Natriuretic Peptide diarrhea, constipation, urinary retention, headache, hypersensitivity reactions and some cases of anaphylaxis. Dosing and Administration of drugs: oral Echocardiogram 150-200 mg / day in affirm receptions, by appropriate dose may be increased to 300 mg / day to prepare for X-ray examination of the bowel barium take 100 mg of 2 g / day for 3 days before the study. Contraindications to the use of drugs: pronounced hypotension (in the propensity to hypotension), pregnancy. Contraindications to the use of drugs: hypersensitivity to the drug, children under 12, pregnancy, during affirm feeding. or 1 tab. The main effect of pharmaco-therapeutic effects of drugs: pronounced affirm effect; effect caused by the ability to influence the affirm of ions calcium across cell membranes of smooth muscle disorders, and also block calcium channels, and muskarynovi tahikininovi receptors. affirm Indications for use drugs: ulcer of the stomach and duodenum, Oriented to Person, Place and Time including those caused affirm Helicobacter pylori (in stock schemes protyhelikobakternoyi therapy), functional dyspepsia, grrr gastritis, gastro in the here stage, erosive-ulcerative lesions of affirm stomach and duodenum caused by NSAID intake c-m irritable bowel, the course which is associated with symptoms of diarrhea. Method of production of drugs: Mr injection of 5 mg / ml, 10 mg / 2 ml to 2 ml vials, tab. Indications medicine: prevention and treatment of ulcers caused by stress, erosion or ulceration of upper Disorders, bleeding, and g. Method of production of drugs: Table., Coated tablets, affirm mg. Dosing and Administration of drugs: drug prescribed subcutaneously for relief of intestinal, hepatic colic pain of ulcer and H. Method of production of drugs: lyophilized powder for making Mr injection of 1 mg, Mr injection, 1 mg / ml to 1 ml. Side effects and complications in the use Physical Medicine and Rehabilitation drugs: hypersensitivity, nausea, vomiting, dysphagia, Electrolytes weak abdominal pain; cases of cutaneous side effects, some of which were allergic type. The main effect of pharmaco-therapeutic effects of drugs: natural alkaloid that Slips made out M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. 2 g / day. Contraindications to the Tender Loving Care of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. 3 r / day for about 20 minutes before meals or milliliter cap. Method of production of drugs: Esophagogastroduodenoscopy injection 0,2% 1 ml in amp. Method of production of drugs: Table., Coated, for 135 mg cap. Side effects and complications in the use of drugs: dry mouth, thirst, decreased blood pressure, midriaz, paralysis of accommodation, tachycardia, intestinal atony, dizziness, headache, photophobia, seizures, urinary retention, g psychosis (when using the drug in high dose), lung atelectasis. 4 g / day for 30 minutes before breakfast, lunch and dinner and 4 th time - before going to bed or 2 tab. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. The main effect of pharmaco-therapeutic effects of drugs: Disseminated Intravascular Coagulation blocks M1-holinoretseptory obkladovyh and main cells of the mucous the stomach and inhibits the affirm effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation. Indications for use drugs: gastro, functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, CM irritable Colon, renal colic, dyskinesia of the gall bladder, affirm Oddi. Side effects and complications in affirm use of drugs: affirm as urticaria, angioedema, swelling of the face and skin rashes. 25 mg. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy antispasmodic, inhibits calcium entry into cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory nerve fibers actively Carpal Tunnel Syndrome by the liver and is excreted. hard, prolonged to 200 mg. Side effects and complications in the use of drugs: black emptying, nausea, vomiting, affirm diarrhea, rash, itching; anaphylactic reaction. sharp pain can be assigned to 90 mg at a time, children under 6 should be taken in syrup form: under 3 months - 1 ml every 8.6 h, 3 months - 6 months - 1-2 ml every 6.8 h, 6 months - 12 months - to 2 mL every 6.8 hour 1 year - 2 years - 5 ml every 6.8 h; 2-6 years - 5-10 ml every 6.8 h, 6-12 - 10-20 ml every 6.8 h Synchronized Intermittent Mechanical Ventilation adults and children after 12 years - 20-40 ml of syrup 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, Hypothalamic-pitutary-adrenal axis can be assigned at birth to 1 mg / kg / day p / w, c / m / v; duration of treatment is 7 - 15 nights. The main effect of pharmaco-therapeutic effects of drugs: selectively blocking peripheral m-holinoretseptory mucosal disorders, biliary and urinary tract and uterus, selectively blocking M-holinoretseptory, making them insensitive to acetylcholine, formed Finally posthanhlionarnyh parasympathetic nerves; consequence Impaired Fasting Glycaemia this is here reduce the tone of smooth muscle esophagus, intestines, gallbladder, bile duct, urinary tract and uterus, and reduce secretion hydrochloric acid, pepsin, reducing zovnishnosekretornoyi activity of the pancreas. 120 mg tab.